P Vittal, C Pulliam, C Goetz, J Jankovic, J Ramirez-Castaneda, D Heldman 18th International Congress of Parkinson’s Disease and Movement Disorders, Stockholm, Sweden, 2014
P Vittal, C Pulliam, C Goetz, J Jankovic, J Ramirez-Castaneda, D Heldman 18th International Congress of Parkinson’s Disease and Movement Disorders, Stockholm, Sweden, 2014
VIEW PRESS RELEASE 15 APR 2014: Valley View, OH – Great Lakes NeuroTechnologies (GLNT) announced today they will be using a $1.5M award from NIH to expand their Parkinson’s monitoring technology to mobile applications. Repositioning GLNT’s Kinesia™ product line with…
A. Espay, M. Edwards, G. Oggioni, N. Phielipp, B. Cox, H. Gonzalez-Usigli, C. Pecina, D. Heldman, J. Mishra, A. Lang Parkinsonism Relat Disord. 2014;20(6):647–50.
VIEW PRESS RELEASE [PDF] 22 JUL 2013: Valley View, OH – Great Lakes NeuroTechnologies announced today they have received allowance of claims from the U.S. Patent Office for an application covering their system and method of stimulating the brain during…
VIEW PRESS RELEASE [PDF] 22 JAN 2013: Valley View, OH – Great Lakes NeuroTechnologies (GLNT) announced today that they are launching a study to determine the feasibility of using intelligent algorithms to assist with programming deep brain stimulation settings for…
VIEW PRESS RELEASE [PDF] 9 JAN 2013: Valley View, OH – Great Lakes NeuroTechnologies announced today that they received TGA approval to market Kinesia technology in Australia. The Kinesia™ product line [ http://glneurotech.com/kinesia/ ] includes patient-worn motion sensors and a…
VIEW PRESS RELEASE [PDF] 08 AUG 2012: Valley View, OH – Great Lakes NeuroTechnologies [ http://www.glneurotech.com ] announced today that they have received $1.5 million in funding to commercialize a technology for Parkinson’s disease (PD) patients that will better assess…
A. Ridgel, M. Muller, C. Kim, E. Fickes, T. Mera Phys Sportsmed. 2011 Sep;39(3):83-93
J. Giuffrida, A. Lerner, R. Steiner, J. Daly IEEE Trans Neural Syst Rehabil Eng. 2008 Feb;16(1):82-90
VIEW PRESS RELEASE [PDF] CLEVELAND, OHIO, October 24, 2006 – Cleveland Medical Devices Inc. (CleveMed) has been awarded a $896,000 Phase II grant from the National Institute of Neurological Disorders and Stroke (NINDS) of the National Institutes of Health (NIH)…